J Korean Med Sci.  2014 Sep;29(9):1325-1327. 10.3346/jkms.2014.29.9.1325.

Seroprevalence of Respiratory Syncytial Virus IgG among Healthy Young Adults in Basic Training for the Republic of Korea Air Force

• Park WJ

• KMID: 1794615
• DOI: http://doi.org/10.3346/jkms.2014.29.9.1325

Abstract

This investigation enrolled 570 healthy young males gathered from all over the country for military service at the Republic of Korea Air Force boot camp. It confirmed RSV IgG seroprevalence by utilizing the enzyme immunoassay method just prior to undergoing basic training. The mean age of this study was 20.25+/-1.34 yr old. The results of their immunoassay seroprofiles showed that 561 men (98.4%) were positive, 2 (0.4%) were negative and 7 (1.2%) were equivocal belonging to the grey zone. It was confirmed that RSV is a common respiratory virus and RSV infection was encountered by almost all people before reaching adulthood in Korea. Nine basic trainees belonging to the RSV IgG negative and equivocal grey zone categories were prospectively observed for any particular vulnerability to respiratory infection during the training period of two months. However, these nine men completed their basic training without developing any specific respiratory illness.

Keyword

Antibodies; Military Facilities; Military Personnel; Respiratory Syncytial Virus Infections

MeSH Terms

Adult
Antibodies, Viral/*blood
Humans
Immunoenzyme Techniques
Immunoglobulin G/*blood
Male
Military Personnel
Respiratory Syncytial Virus Infections/*epidemiology
Respiratory Syncytial Viruses/*immunology
Seroepidemiologic Studies
Young Adult
Antibodies, Viral
Immunoglobulin G

Figure

• 

  Fig. 1 Distribution of individual titers for respiratory syncytial virus IgG.

Reference

1. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis. 1999; 5:379–385.

2. O'Shea MK, Pipkin C, Cane PA, Gray GC. Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training. Influenza Other Respir Viruses. 2007; 1:193–197.

3. O'Shea MK, Ryan MA, Hawksworth AW, Alsip BJ, Gray GC. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis. 2005; 41:311–317.

4. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA, editors. Medical microvirology. 4th ed. St. Louis: Mosby;2002.

5. Kim JK, Jeon JS, Kim JW, Rheem I. Epidemiology of respiratory viral infection using multiplex rt-PCR in Cheonan, Korea (2006-2010). J Microbiol Biotechnol. 2013; 23:267–273.

6. Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, Shin BM. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008. J Korean Med Sci. 2010; 25:342–347.

7. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001; 344:1917–1928.

8. Eick AA, Faix DJ, Tobler SK, Nevin RL, Lindler LE, Hu Z, Sanchez JL, MacIntosh VH, Russell KL, Gaydos JC. Serosurvey of bacterial and viral respiratory pathogens among deployed U.S. service members. Am J Prev Med. 2011; 41:573–580.

9. Bhattarakosol P, Pancharoen C, Mungmee V, Thammaborvorn R, Semboonlor L. Seroprevalence of anti-RSV IgG in Thai children aged 6 months to 5 years. Asian Pac J Allergy Immunol. 2003; 21:269–271.

10. Lu G, Gonzalez R, Guo L, Wu C, Wu J, Vernet G, Paranhos-Baccalà G, Wang J, Hung T. Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China. Virol J. 2011; 8:62.

11. Anderson LJ, Heilman CA. Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis. 1995; 171:1–7.

12. Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis. 1998; 177:463–466.

13. Luchsinger V, Piedra PA, Ruiz M, Zunino E, Martínez MA, Machado C, Fasce R, Ulloa MT, Fink MC, Lara P, et al. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus. Clin Infect Dis. 2012; 54:905–912.

14. Ochola R, Sande C, Fegan G, Scott PD, Medley GF, Cane PA, Nokes DJ. The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLoS One. 2009; 4:e8088.

15. Roca A, Abacassamo F, Loscertales MP, Quintó L, Gómez-Olivé X, Fenwick F, Saiz JC, Toms G, Alonso PL. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique. J Med Virol. 2002; 67:616–623.

16. Cherukuri A, Patton K, Gasser RA Jr, Zuo F, Woo J, Esser MT, Tang RS. Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein. Clin Vaccine Immunol. 2013; 20:239–247.

17. Ham H, Jang J, Choi S, Oh S, Jo S, Choi S, Pak S. Epidemiological characterization of respiratory viruses detected from acute respiratory patients in Seoul. Ann Clin Microbiol. 2013; 16:188–195.

18. Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012; 12:98–102.

19. Mehta J, Walsh EE, Mahadevia PJ, Falsey AR. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. COPD. 2013; 10:293–299.